Preferentially expressed antigen of melanoma prevents lung cancer metastasis

  • Quan Huang
  • , Haifeng Wei
  • , Zhipeng Wu
  • , Lin Li
  • , Liangfang Yao
  • , Zhengwang Sun
  • , Lei Li
  • , Zaijun Lin
  • , Wei Xu
  • , Shuai Han
  • , Wenjiao Cao
  • , Yunfei Xu
  • , Dianwen Song
  • , Xinghai Yang
  • , Jianru Xiao

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Lung cancer is the most common cause of cancer death worldwide. The poor survival rate is largely due to the extensive local invasion and metastasis. However, the mechanisms underlying the invasion and metastasis of lung cancer cells remain largely elusive. In this study, we examined the role of preferentially expressed antigen of melanoma (PRAME) in lung cancer metastasis. Our results show that PRAME is downregulated in lung adenocarcinoma and lung bone metastasis compared with normal human lung. Knockdown of PRAME decreases the expression of E-Cadherin and promotes the proliferation, invasion, and metastasis of lung cancer cells by regulating multiple critical genes, most of which are related to cell migration, including MMP1, CCL2, CTGF, and PLAU. Clinical data analysis reveals that the expression of MMP1 correlates with the clinical features and outcome of lung adenocarcinoma. Taken together, our data demonstrate that PRAME plays a role in preventing the invasion and metastasis of lung adenocarcinoma and novel diagnostic or therapeutic strategies can be developed by targeting PRAME.

Original languageEnglish
Article numbere0149640
JournalPLoS ONE
Volume11
Issue number7
DOIs
StatePublished - Jul 2016

Fingerprint

Dive into the research topics of 'Preferentially expressed antigen of melanoma prevents lung cancer metastasis'. Together they form a unique fingerprint.

Cite this